The interaction between HCV and nuclear receptor-mediated pathways

Zoe Raglow, Carly Thoma-Perry, Richard Gilroy, Yu-Jui Yvonne Wan

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Hepatitis C virus (HCV) is presently the leading indication for liver transplantation in Western countries. Treatment for HCV infection includes a combination of pegylated interferon and ribavirin, which produces highly variable response rates. This reflects the lack of information regarding the roles of host and viral components during viral pathogenesis. Vital processes regulated by the liver, including metabolism, lipid homeostasis, cellular proliferation, and the immune response, are known to be systematically dysregulated as a result of persistent HCV infection. Nuclear receptors and their ligands are recognized as indispensable regulators of liver homeostasis. Pathways mediated by the nuclear receptor superfamily have been shown to be profoundly disrupted during HCV infection, leading to an increased importance in elucidating the exact nature of this complex relationship. Expanded understanding of the role of nuclear receptors in HCV infection may therefore be an essential step in the search for a more universally effective treatment.

Original languageEnglish (US)
Pages (from-to)30-38
Number of pages9
JournalPharmacology and Therapeutics
Volume132
Issue number1
DOIs
StatePublished - Oct 2011
Externally publishedYes

Fingerprint

Virus Receptors
Cytoplasmic and Nuclear Receptors
Hepacivirus
Virus Diseases
Homeostasis
Viral Structures
Ribavirin
Liver
Lipid Metabolism
Cellular Immunity
Liver Transplantation
Interferons
Cell Proliferation
Ligands
Therapeutics

Keywords

  • Autophagy
  • Hepatitis
  • Liver
  • Retinoic acid
  • Retinoic acid receptor
  • Steatosis

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)

Cite this

The interaction between HCV and nuclear receptor-mediated pathways. / Raglow, Zoe; Thoma-Perry, Carly; Gilroy, Richard; Wan, Yu-Jui Yvonne.

In: Pharmacology and Therapeutics, Vol. 132, No. 1, 10.2011, p. 30-38.

Research output: Contribution to journalArticle

Raglow, Zoe ; Thoma-Perry, Carly ; Gilroy, Richard ; Wan, Yu-Jui Yvonne. / The interaction between HCV and nuclear receptor-mediated pathways. In: Pharmacology and Therapeutics. 2011 ; Vol. 132, No. 1. pp. 30-38.
@article{43bfec8f6ae84ce481fdb78ed31f6645,
title = "The interaction between HCV and nuclear receptor-mediated pathways",
abstract = "Hepatitis C virus (HCV) is presently the leading indication for liver transplantation in Western countries. Treatment for HCV infection includes a combination of pegylated interferon and ribavirin, which produces highly variable response rates. This reflects the lack of information regarding the roles of host and viral components during viral pathogenesis. Vital processes regulated by the liver, including metabolism, lipid homeostasis, cellular proliferation, and the immune response, are known to be systematically dysregulated as a result of persistent HCV infection. Nuclear receptors and their ligands are recognized as indispensable regulators of liver homeostasis. Pathways mediated by the nuclear receptor superfamily have been shown to be profoundly disrupted during HCV infection, leading to an increased importance in elucidating the exact nature of this complex relationship. Expanded understanding of the role of nuclear receptors in HCV infection may therefore be an essential step in the search for a more universally effective treatment.",
keywords = "Autophagy, Hepatitis, Liver, Retinoic acid, Retinoic acid receptor, Steatosis",
author = "Zoe Raglow and Carly Thoma-Perry and Richard Gilroy and Wan, {Yu-Jui Yvonne}",
year = "2011",
month = "10",
doi = "10.1016/j.pharmthera.2011.05.005",
language = "English (US)",
volume = "132",
pages = "30--38",
journal = "Pharmacology and Therapeutics",
issn = "0163-7258",
publisher = "Elsevier Inc.",
number = "1",

}

TY - JOUR

T1 - The interaction between HCV and nuclear receptor-mediated pathways

AU - Raglow, Zoe

AU - Thoma-Perry, Carly

AU - Gilroy, Richard

AU - Wan, Yu-Jui Yvonne

PY - 2011/10

Y1 - 2011/10

N2 - Hepatitis C virus (HCV) is presently the leading indication for liver transplantation in Western countries. Treatment for HCV infection includes a combination of pegylated interferon and ribavirin, which produces highly variable response rates. This reflects the lack of information regarding the roles of host and viral components during viral pathogenesis. Vital processes regulated by the liver, including metabolism, lipid homeostasis, cellular proliferation, and the immune response, are known to be systematically dysregulated as a result of persistent HCV infection. Nuclear receptors and their ligands are recognized as indispensable regulators of liver homeostasis. Pathways mediated by the nuclear receptor superfamily have been shown to be profoundly disrupted during HCV infection, leading to an increased importance in elucidating the exact nature of this complex relationship. Expanded understanding of the role of nuclear receptors in HCV infection may therefore be an essential step in the search for a more universally effective treatment.

AB - Hepatitis C virus (HCV) is presently the leading indication for liver transplantation in Western countries. Treatment for HCV infection includes a combination of pegylated interferon and ribavirin, which produces highly variable response rates. This reflects the lack of information regarding the roles of host and viral components during viral pathogenesis. Vital processes regulated by the liver, including metabolism, lipid homeostasis, cellular proliferation, and the immune response, are known to be systematically dysregulated as a result of persistent HCV infection. Nuclear receptors and their ligands are recognized as indispensable regulators of liver homeostasis. Pathways mediated by the nuclear receptor superfamily have been shown to be profoundly disrupted during HCV infection, leading to an increased importance in elucidating the exact nature of this complex relationship. Expanded understanding of the role of nuclear receptors in HCV infection may therefore be an essential step in the search for a more universally effective treatment.

KW - Autophagy

KW - Hepatitis

KW - Liver

KW - Retinoic acid

KW - Retinoic acid receptor

KW - Steatosis

UR - http://www.scopus.com/inward/record.url?scp=79960596493&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79960596493&partnerID=8YFLogxK

U2 - 10.1016/j.pharmthera.2011.05.005

DO - 10.1016/j.pharmthera.2011.05.005

M3 - Article

C2 - 21620888

AN - SCOPUS:79960596493

VL - 132

SP - 30

EP - 38

JO - Pharmacology and Therapeutics

JF - Pharmacology and Therapeutics

SN - 0163-7258

IS - 1

ER -